| 697448 |
NEURO-ONCOLOGY |
EMBR-32. INTEGRATED STRESS RESPONSE PLAYS A PRO-SURVIVAL ROLE IN MYC-DRIVEN MEDULLOBLASTOMA |
2021-06-01 |
10.1093/neuonc/noab090.049 |
Langman Sofya, Delaidelli Alberto, Huang Yue Zhou, Sorensen Poul |
| 697447 |
NEURO-ONCOLOGY |
HGG-38. DE NOVO PYRIMIDINE SYNTHESIS INHIBITION INDUCES REPLICATION CATASTROPHE MEDIATED CELL DEATH IN DIFFUSE MIDLINE GLIOMA |
2021-06-01 |
10.1093/neuonc/noab090.102 |
Pal Sharmistha, Kaplan Jakub, Stopka Sylwia, Regan Michael, Kann Benjamin, Agar Nathalie, Stiles Charles, Cooney Tabitha, Mueller Sabine, Chowdhury Dipanjan, Haas-Kogan Daphne |
| 697446 |
NEURO-ONCOLOGY |
HGG-05. NEURONAL ACTIVITY PROMOTES PEDIATRIC HIGH-GRADE GLIOMA GROWTH THROUGH A NLGN3-CSPG4 SIGNALING AXIS |
2021-06-01 |
10.1093/neuonc/noab090.071 |
Gillespie Shawn, Kim Yoon, Geraghty Anna, Woo Pamelyn, Monje Michelle |
| 697445 |
NEURO-ONCOLOGY |
EMBR-08. CORRELATION OF HISTOPATHOLOGY, CHROMOSOMAL MICROARRAY, AND NANOSTRING BASED 22-GENE ASSAY FOR MEDULLOBLASTOMA SUBGROUP ASSIGNMENT ON “HEAD START” 4 CLINICAL TRIAL |
2021-06-01 |
10.1093/neuonc/noab090.026 |
Dhall Girish, Patel Parth, Blue Megan, Biegel Jaclyn, Almiraz-Suarez Isabel, Hwang Eugene, Pierson Christopher, Boue Daniel, Finlay Jonathan |
| 697444 |
NEURO-ONCOLOGY |
EPCT-02. COMPARISON OF TARGETED AGENTS RECOMMENDED BY THE CNS-TAP TOOL TO THOSE SELECTED BY A TUMOR BOARD IN A MOLECULARLY-DRIVEN DIPG CLINICAL TRIAL |
2021-06-01 |
10.1093/neuonc/noab090.188 |
Roberts Holly, Ravi Karthik, Marini Bernard, Kline Cassie, Mueller Sabine, Koschmann Carl, Franson Andrea |
| 697443 |
NEURO-ONCOLOGY |
RARE-20. A RARE CASE OF A PRIMARY CENTRAL NERVOUS SYSTEM NEUROENDOCRINE CARCINOMA AND SUCCESSFULL THERAPY IN A FIVE-YEAR-OLD CHILD |
2021-06-01 |
10.1093/neuonc/noab090.181 |
Stepien Natalia, Haberler Christine, Schmook Maria-Theresa, Gojo Johannes, Azizi Amedeo A, Czech Thomas, Slavc Irene, Peyrl Andreas |
| 697442 |
NEURO-ONCOLOGY |
EPCT-18. A TWO-PART, PHASE 1 STUDY OF RHENIUM-186 NANOLIPOSOME (186RNL) DELIVERED BY CONVECTION ENHANCED DELIVERY FOR RECURRENT, REFRACTORY, OR PROGRESSIVE EPENDYMOMA AND HIGH-GRADE GLIOMA (HGG) AND NEWLY DIAGNOSED DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG) |
2021-06-01 |
10.1093/neuonc/noab090.204 |
Plant Ashley, Goldman Stewart, Lam Sandi, DeCuypere Michael, Stein Gregory, Brenner Andrew |
| 697441 |
NEURO-ONCOLOGY |
RARE-06. CLINICAL BURDEN AMONG PATIENTS WITH NEUROFIBROMATOSIS TYPE 1 (NF1) AND PLEXIFORM NEUROFIBROMA (PN) IN THE UNITED STATES (US) |
2021-06-01 |
10.1093/neuonc/noab090.167 |
Yang Xiaoqin, Yoo Hyun Kyoo, Amin Suvina, Cheng Wendy, Sipsma Heather, Sundaresan Sanjana, Zhang Lujia, Duh Mei Sheng |
| 697440 |
NEURO-ONCOLOGY |
LGG-02. PEDIATRIC LOW-GRADE GLIOMA RISK STRATIFICATION IN THE MOLECULAR ERA |
2021-06-01 |
10.1093/neuonc/noab090.126 |
Hata Jessica, Barbour Mustafa, Huang Michael Angelo |
| 697439 |
NEURO-ONCOLOGY |
HGG-08. CREATION OF AN IN VITRO AND IN VIVO MODEL SYSTEM FOR THE STUDY OF H3.1K27M DIPG |
2021-06-01 |
10.1093/neuonc/noab090.074 |
Lagas Joseph, Yang Lihua, Becher Oren, Rubin Joshua |
